Načítá se...
Anti-CD19 chimeric antigen receptor targeting of CD19 + acute myeloid leukemia
Aberrant expression of CD19 in acute myeloid leukemia (AML) is commonly associated with t(8;21)(q22;q22), although AML cases lacking this translocation occasionally express CD19. Mixed-phenotype acute leukemia also frequently expresses CD19. Chimeric antigen receptor (CAR) technology is a major brea...
Uloženo v:
| Vydáno v: | Leuk Res Rep |
|---|---|
| Hlavní autoři: | , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Elsevier
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5993359/ https://ncbi.nlm.nih.gov/pubmed/29892548 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.lrr.2018.03.002 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|